Find clinical trials for Eli Lilly. Search for Eli Lilly clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 107
A Study of Brenipatide in Participants With Alcohol Use Disorder
for
Alcohol Use Disorder
Location: Middleburg Heights OH
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07219953
Phase 3, Recruiting
A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive Complaint
for
Subjective Cognitive Impairment
Location: New York NY
Sponsor: Eli Lilly and Company
Sex: All
Age: 50+
Code: NCT07140744
Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
for
Ovarian Neoplasms, Breast Neoplasms,
Location: Boston MA, New York NY, Philadelphia PA, Glen Burnie MD,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213791
Phase 1, Recruiting
A Study of LY4178256 in Healthy Participants
for
Healthy Volunteers
Location: Salt Lake City UT
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 65
Code: NCT07698210
Phase 1, Recruiting
Epidemiology and Biomarker Study in Alzheimer's Disease
for
Alzheimer Disease
Location: Houston TX
Sponsor: Eli Lilly and Company
Sex: All
Age: 55 - 70+
Code: NCT07142954
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of LY4175408 in Participants With Advanced Cancer
for
Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma,
Location: Boston MA, New York NY, Hackensack NJ, Fairfax VA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07046923
Phase 1, Recruiting
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
for
Breast Neoplasms
Location: Shirley NY, Fairfax VA, Indianapolis IN, Nashville TN,
Sponsor: Eli Lilly and Company
Sex: Female
Age: 18+
Code: NCT07287098
Phase 2, Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for
Alzheimer Disease, Dementia, Plaque, Amyloid
Location: Newton MA, Springfield NJ, Aventura FL, Miami FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 55+
Code: NCT07602582
Phase 3, Recruiting
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Location: Boston MA, Lake Success NY, New York NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06876649
Recruiting
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: Boston MA, New York NY, Cleveland OH, Grand Rapids MI,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06465069
Phase 1, Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for
Ulcerative Colitis, Obesity or Overweight
Location: London, New Bedford MA, Providence RI, Lebanon NH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937086
Phase 3, Recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
for
Crohn's Disease, Obesity or Overweight
Location: London, New Bedford MA, Providence RI, Lebanon NH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937099
Phase 3, Recruiting
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Location: Boston MA, Lake Success NY, New York NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06876662
Recruiting
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
for
Obesity, Weight Gain
Location: Hamilton
Sponsor: Eli Lilly and Company
Sex: All
Age: 12 - 17
Code: NCT06439277
Phase 3, Recruiting
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
for
Primary Myelofibrosis
Location: Boston MA, New York NY, Charlotte NC, Tampa FL,
Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06343805
Phase 1, Recruiting
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata